AG
PMD

Algert Global’s Psychemedics Corporation PMD Stock Holding History

Algert Global’s Portfolio PMD Stock Details PMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q1 		– Sell
-10,384
Closed -$213K – 382
2017
Q4 		$213K Buy
+10,384
New +$193K 0.05% 282
2017
Q3 		– Sell
-54,761
Closed -$1.37M – 353
2017
Q2 		$1.37M Buy
54,761
+1,350
+3% +$28.4K 0.38% 119
2017
Q1 		$1.07M Buy
53,411
+33,362
+166% +$732K 0.29% 148
2016
Q4 		$495K Buy
20,049
+9,715
+94% +$218K 0.14% 232
2016
Q3 		$205K Buy
+10,334
New +$192K 0.06% 335

Other funds holding PMD

Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
MC
Moors & Cabot Boston, Massachusetts $2.34B AUM 30.42% 1-Year Est. Return
TCM
Tieton Capital Management Yakima, Washington $299M AUM 54.55% 1-Year Est. Return
CIC
Crawford Investment Counsel Atlanta, Georgia $5.85B AUM 12.61% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
UIC
Uniplan Investment Counsel Milwaukee, Wisconsin $974M AUM 21.37% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
William Blair & Company
William Blair & Company Chicago, Illinois $34.9B AUM 18.88% 1-Year Est. Return
NSIM
North Star Investment Management Chicago, Illinois $1.65B AUM 20.56% 1-Year Est. Return
RC
RBF Capital San Francisco, California $2.05B AUM 29.64% 1-Year Est. Return

Algert Global's PMD Position: Q1 2018 in Review

Algert Global sold out of Psychemedics Corporation (PMD) in Q1 2018, closing a stake of 10,384 shares — an estimated $213K sold.

Algert Global first reported a position in PMD in Q3 2016 and held it in 5 quarters. The position peaked at $1.37M in Q2 2017. 50 funds tracked by Wall St. Rank hold PMD as of Q1 2018.

  • Algert Global reported no remaining Psychemedics Corporation position as of Q1 2018 after selling out during the quarter.
  • Algert Global sold 10,384 Psychemedics Corporation shares in Q1 2018, an estimated $213K.
  • Algert Global first reported a position in Psychemedics Corporation in Q3 2016 and held it in 5 quarters.
  • Algert Global's Psychemedics Corporation position peaked at $1.37M in Q2 2017.
  • 50 funds tracked by Wall St. Rank held Psychemedics Corporation as of Q1 2018.

Based on Algert Global's 13F filing for Q1 2018, filed 3 May 2018.